Final answer:
False positives in breast cancer screening, referred to as FALSE (+)'s, are false-positive test results where a diagnostic test incorrectly indicates cancer. Magnetic Resonance Imaging (MRI) is used alongside mammograms to reduce false positives. These terms refer to the accuracy of diagnostic tests in identifying breast cancer.
Step-by-step explanation:
False positives, commonly referred to as FALSE (+)'s, in the context of breast cancer screening, are D) False-positive test results. These occur when a mammogram or other diagnostic test indicates the presence of cancer when it is not actually there. False positives can cause unnecessary stress for patients and may lead to additional testing, such as a biopsy, to confirm the diagnosis.
In terms of neoplasm, a benign tumor is a growth that remains localized and is generally not life-threatening, though some benign tumors may have the potential to become malignant. Magnetic Resonance Imaging (MRI) is often used to supplement x-ray diagnostics, including mammograms, to improve detection of breast cancer and to help reduce the incidence of false positives, offering a more contrasted view of breast tissue.
It's important to note that breast cancer screening methods, like all medical tests, are not perfect and can sometimes yield false positive or false negative results. Screening techniques continue to evolve to provide more accurate and reliable results for early detection of breast cancer.